|
HS Code |
917165 |
| Chemical Name | Tocopheryl Polyethylene Glycol Succinate |
| Common Abbreviation | TPGS |
| Cas Number | 9002-96-4 |
| Appearance | Waxy solid or viscous liquid |
| Solubility | Soluble in water and organic solvents |
| Molecular Formula | C33H54O5(C2H4O)n |
| Ph | Approximately 6-8 (1% aqueous solution) |
| Melting Point | 37-41°C |
| Function | Non-ionic surfactant and solubilizer |
| Origin | Synthetic derivative of vitamin E |
As an accredited Tocopheryl Polyethylene Glycol Succinate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Tocopheryl Polyethylene Glycol Succinate is packaged in a 500g opaque plastic bottle with tamper-evident seal and product labeling. |
| Shipping | Tocopheryl Polyethylene Glycol Succinate is typically shipped in sealed, HDPE drums or containers to protect from moisture and contamination. It is transported as a non-hazardous material under normal conditions, but should be stored in a cool, dry place, away from direct sunlight, and handled with standard precautions appropriate for chemical substances. |
| Storage | Tocopheryl Polyethylene Glycol Succinate should be stored in a tightly closed container, away from light, heat, and moisture. Ideally, keep it at controlled room temperature (15°C–30°C/59°F–86°F). Avoid exposure to direct sunlight and incompatible substances such as strong oxidizing agents. Ensure the storage area is dry, well-ventilated, and complies with chemical safety regulations to maintain product stability and quality. |
Competitive Tocopheryl Polyethylene Glycol Succinate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In chemical manufacturing, every batch tells a story—attention to each detail shapes not just the product, but the difference it brings downstream. Tocopheryl polyethylene glycol succinate, often called TPGS, stands out in our production lines for good reason. Over the years, the demand for TPGS has surged, especially in the pharmaceutical and nutraceutical industries. Our customers turn to us for TPGS because they’ve experienced the reliability of a product whose manufacturing process is tightly controlled, free from shortcuts and unnecessary additives. Production isn’t about ticking boxes—it’s about understanding what users need, and providing that consistently.
In our facility, we manufacture TPGS using food-grade tocopherol and polyethylene glycol selected after detailed evaluation for purity and compatibility. Each stage—from esterification to purification—relies on tried-and-tested protocols, constant monitoring, and batch traceability. No batch leaves without meeting set specifications for free tocopherol content, polyethylene glycol chain length, and acidity index. Our technicians know that the smallest deviation can compromise performance in the final application, whether it’s a capsule, an oral solution, or a cream for sensitive skin.
Experience has shown that not all TPGS products perform equally. The purity of tocopherol, consistency in polyethylene glycol blending, and the completeness of the succinylation reaction all impact performance. Formulators tell us that, in some cases, even a slight shift in molecular weight distribution or residual reactants can cause cloudiness, texture changes, or loss of clarity in aqueous solutions. By taking time to develop in-house quality control benchmarks above the minimum, we reduce unexpected surprises later in the process.
Our grades—often detailed as TPGS 1000, referencing the PEG chain length—are produced to deliver predictable water solubility and emulsifying power. Customers working with complex pharmaceuticals find that the right TPGS grade improves not only bioavailability, but also the stability of lipid-based active ingredients. Over years, we’ve observed fewer rejections, less wastage, and better batch-to-batch reproducibility—facts that matter on the production floor and in the boardroom.
Industries use different grades of TPGS, but in our manufacturing base we see most demand centered around TPGS 1000. This model reflects a balance between hydrophilic and lipophilic properties. The polyethylene glycol segment, pegged at roughly 1000 daltons, keeps the compound soluble in water while still tethered to a vitamin E backbone. One recurring comment we hear from customers is how much easier it is to dissolve actives with this grade, compared to traditional forms of vitamin E which prefer oily environments.
Our regular production focus keeps specifications tight. We ensure the product holds a bright, pale yellow appearance, with no burnt or off notes from high-temperature synthesis. Each lot achieves low acid value and meets target saponification numbers. Moisture is controlled below a set threshold as it influences powder flow and shelf stability. Our process avoids preservatives or anti-caking agents, so nothing interferes with sensitive formulation environments.
Colleagues in R&D have often remarked on the versatility of TPGS. In pharmaceuticals, it earns its place as a potent solubilizer and absorption enhancer. Formulators tackling poorly soluble drugs often face the challenge of increasing solubility without triggering instability or unwanted interactions. TPGS’s amphiphilic nature handles this delicate balance: the tocopherol part anchors in a lipid environment, while the PEG chains reach into water, carrying otherwise-insoluble compounds into solution.
We’ve run tests in-house and worked alongside client labs to optimize formulations for soft-gel capsules, oral suspensions, and parenteral solutions. In many cases, TPGS not only increases drug solubility but also protects sensitive molecules from oxidation. Our production crew notes far fewer crystallization or precipitation issues in these products.
In the world of nutritional supplements, TPGS enables nutritional actives to reach a broader user base. Vitamin E, as d-alpha tocopherol, does not always display good bioavailability in traditional oil-based forms, especially in people with compromised lipid absorption. Customers point out that TPGS’s function as a water-dispersible vitamin E source is critical for developing products aimed at those with malabsorption syndrome, cystic fibrosis, or similar conditions. Our approach—keeping residual solvents and byproducts to a minimum—means we can guarantee a product suitable for these sensitive market segments.
Years of running reactors, columns, and driers have taught us that even small changes in process conditions carry lasting effects. Run temperature too high and the risk of off-notes, discoloration, or degradation increases. Rush purification and trace reactants may slip through, compromising taste, safety, or regulatory compliance. This is where our commitment to manufacturing discipline comes in. By retaining tight control over synthesis parameters, we maintain both purity and yield.
Our technical team spends as much time on cleaning and equipment inspection as on actual synthesis. Only food-grade and pharmaceutical-grade lines handle TPGS destined for ingestible or topical use, preventing cross-contamination. Inline sensors monitor reactant levels, and tests for peroxide and acid value are run before every packaging step. These safeguards come from real-world experience, not just recommendations on paper.
Some may compare TPGS to polysorbates, lecithins, or other PEGylated surfactants. While each class brings its own strengths, TPGS stands out in a few clear ways. The vitamin E core gives intrinsic antioxidant activity—this matters for actives sensitive to oxidation, a fact we’ve seen proven in customer stability studies. We’ve also observed TPGS showing lower irritancy potential in human patch tests compared to some synthetic surfactants.
Unlike polysorbate 80 or 20, which can contain impurities from fatty acid sources, our TPGS manufacturing relies exclusively on plant-derived vitamin E and top-quality PEG. No animal-based contaminants, ethylene oxide residues, or heavy metal traces show up in our in-house screenings. Consistency from batch to batch supports both regulatory filings and long-term production plans. Partners in the infant nutrition sector underscore the value of this attention to raw material sourcing, especially under new global scrutiny on traceability.
With new therapies and nutritional trends emerging each year, the expectations for excipients keep rising. Our experience with TPGS positions us to meet ambitious formulation goals, whether for nanoemulsions, solid dispersions, or targeted delivery systems. Researchers tell us that TPGS often doubles as a permeability enhancer. In some drug delivery models, beyond simple solubilization, TPGS can inhibit P-glycoprotein, helping drugs penetrate cellular barriers.
We’ve worked on projects that challenged us to match not just solubility, but also taste, dispersibility, and storage stability. On the production floor, we found that TPGS powder flows smoothly through bulk-handling systems, with minimal caking or bridging in silos. Downstream, maintenance teams appreciate how little residue it leaves on filling and packaging lines compared to fatty emulsifiers.
We view regulatory compliance as a starting point, not the limit of our responsibility. All pharma-grade and food-grade TPGS lots undergo tests in line with pharmacopeias such as USP and EP. This means controlling not just purity, but also microbial load, residual solvents, and even elemental impurities. In each regional market, from the US to the EU and Asia-Pacific, our documentation supports customer filings.
Over the last decade, food safety has taken on new urgency. Our process is engineered to eliminate any potential for allergen cross-contact, which our customers in the medical nutrition sector have flagged as non-negotiable. We store and transport TPGS in clean, sealed containers, with tamper-evident seals and regular audits to validate our protocols. Staff training in hygiene and traceability is not optional—it shapes who we are as a manufacturer.
One clear advantage in manufacturing and not just trading is our ability to respond to unique customer challenges. Some clients request lower residual solvents for high-sensitivity APIs. Others value a powder over flakes for shorter dissolution times, or prefer drum, bag, or bulk tote options to fit their equipment setups.
We maintain flexibility without compromising quality. Customer feedback in R&D drives small-batch trials on our pilot reactors. If a new regulatory threshold emerges, our technical staff shifts quickly—running new analytical checks, adjusting purification, or working with suppliers to secure compliant inputs. By keeping open communication with long-term partners, we often get early insights into changing market requirements, which allows our practices to evolve continuously.
Our journey with TPGS is marked by ongoing investment. Upgrading automation, installing fail-safes on mixing and drying equipment, and recruiting qualified analytical chemists have paid off with lower rejection rates and repeat orders from established brands. After raw material prices spiked in previous years, we realized the importance of securing direct sourcing agreements with vitamin E suppliers who meet both purity and documentation standards.
Trust in manufacturing doesn’t build overnight. Customers who’ve visited our facility, questioned our protocols, and reviewed batch records often say that transparency gives them confidence to take on new projects. Loyalty comes from real-world results: shorter development cycles, fewer surprises in stability testing, and easy integration into regulatory submissions.
Managing supply chain uncertainty stands as one of the most persistent challenges. The vitamin E market has seen its share of volatility. Early on, we developed relationships with multiple primary suppliers—if one falls short, production can continue uninterrupted. Buffer stocks and transparent forecasting help even out supply bumps, keeping our customers’ schedules on track.
We’ve also invested in staff training and digital batch management to prevent human errors. Automated alarms and double-verification remove guesswork from critical steps such as PEG addition and neutralization. Every year, we review our process for bottlenecks and contamination risks, drawing from front-line production team feedback as much as from academic literature.
Scalability sometimes raises questions, especially as customer demand fluctuates with new product launches. Our solution anchors on modular reactors and flexible packaging lines. We can increase output in weeks, not months, without risking the tight controls we’ve built over two decades.
We see new opportunities for TPGS in targeted drug delivery, medical nutrition, and even cosmeceutical formulations. Clients in advanced therapy development ask for data on how TPGS interacts with nanoparticles or controlled-release carriers. Fielding these queries means running joint studies, tweaking process parameters, and investing in rapid analytical tools.
Environmental concerns are growing. We have started switching to greener energy sources and designing processes to minimize water and solvent waste. Researchers at partner companies tell us that lifecycle data for excipients like TPGS is increasingly part of procurement decisions. By keeping process waste low, prioritizing sustainable raw materials, and reviewing packaging options, we aim to set a new benchmark for low-impact manufacturing.
In our experience, customers who rely on trader-sourced TPGS often discover inconsistencies only during later batch or regulatory checks. As the direct producer, we make every lot traceable, every process adjustment documented, and every quality control test result open for review. This approach has built resilience into our own supply chains and provides an assurance of authenticity that’s impossible to secure further downstream.
Our team remains committed to continuous improvement—not chasing jargon or marketing trends, but answering to real-world demands. Whether a client is launching a new pediatric supplement or scaling up a trial for a critical therapeutic, we support those goals with high-quality TPGS that meets real challenges, not just checklists.
We view manufacturing as a responsibility, not just a technical achievement. Producing TPGS consistently takes patience, continuous vigilance, and willingness to learn from both successes and failures. Every report from formulation labs, every regulatory audit, and every customer comment guides how we plan the next batch or improve a process.
Our promise is simple: deliver tocopheryl polyethylene glycol succinate with unwavering quality and openness at every step. Through years of focused investment and technical discipline, we have learned that the details—from securing pure inputs to proving batch records—are what set a manufacturer’s product apart in the world of excipients.